New scans aim to replace painful liver biopsies for millions
NCT ID NCT07172997
Summary
This study aims to create better, needle-free ways to screen for and monitor a common fatty liver disease (MASLD) in people undergoing weight-loss surgery. Researchers will also look for signs in the blood that can predict if a person's type 2 diabetes will go away after surgery. They will compare different scans and blood tests against the current standard, a liver biopsy, in 163 patients before and after their operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alhakeem Radiology Center
Manama, Manama, 2901, Bahrain
-
King Hamad University Hospital
Al Muharraq, Muharraq, Bahrain
Conditions
Explore the condition pages connected to this study.